BiondVax Pharmaceuticals Ltd. (American Depositary Shares) is a biopharmaceutical company specializing in the development and commercialization of innovative vaccines targeting viral diseases. With a focus on influenza, BiondVax is dedicated to providing a comprehensive solution that addresses the challenges posed by evolving strains. The company’s approach combines cutting-edge technology with a deep understanding of the immune system to create vaccines that offer broad protection and long-lasting immunity.
